semaglutide patent india Why Delhi HC rejected semaglutide patent suit | Explained News

India is set for a surge in cheaper weight-loss drugs as the patent for semaglutide, used in Ozempic and Wegovy, expires, with generics expected to cut prices by over 50% and expand

25.61

★★★★☆4.8 (126)

As the patents on semaglutide, a popular diabetes and anti-obesity drug that earned its Danish maker Novo Nordisk nearly USD 30 billion in FY25 alone, expire in nearly 100 countries next year,

22.90

★★★★★4.9 (98)

Semaglutide patent expiry in India opens up huge opportunity for generic drugmakers: Report @zydusuniverse Read more link in bio. #Semaglutide #DiabetesCare #ObesityTreatment #PharmaNews #NovoNordisk #DrugPatent

27.16

★★★★★5.0 (157)

Cheap Generic Ozempic To Hit India: Patent Exit Sparks Weight-Loss Drug Boom. The Danish drugmaker's key patent on semaglutide, the active ingredient in Ozempic and Wegovy expires in India on March 20. :

21.97

★★★★★4.7 (84)

#VantageOnFirstpost: Semaglutide Goes Generic in India: Drugs could be as cheap as $14 , India has just entered its Ozempic era. With the patent expiry of Semaglutide, the key ingredient behind

20.04

★★★★★4.9 (203)

Tsunami of weight-loss drugs to take over India today

28.97

★★★★★5.0 (176)

India's semaglutide patent expiry to boost affordable access | Ms. Priyanka S. posted on the topic

28.28

★★★★★4.8 (132)